Comments
Loading...

Lineage Cell Therapeutics Stock Price, Quotes and Forecasts

LCTXAMEX
Logo brought to you by Benzinga Data
$0.6523
-0.03-4.48%
At close: -
$0.6531
0.000800.12%
After Hours: 7:39 PM EDT
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Lineage Cell Therapeutics Stock Price, Quotes and Forecasts | AMEX:LCTX | Benzinga

Explore Lineage Cell Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LCTX.

Open$0.68
Close$0.65
Volume / Avg.1.22M / 1.38M
Day Range$0.64 - $0.69
52 Wk Range0.37 - 1.15
Market Cap$149.14M
P/E Ratio-
Dividend Yield-
ExchangeAMEX
RSI
67
Short Interest
23.42%
Days to Cover40.09
About Lineage Cell Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development a...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LCTX
MOLN

FAQ

Q

How do I buy Lineage Cell Therapeutics (LCTX) stock?

A

You can purchase shares of Lineage Cell Therapeutics (AMEX:LCTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lineage Cell Therapeutics (LCTX) competitors?

Q

What is the forecast, or price target, for Lineage Cell Therapeutics (LCTX) stock?

A

Lineage Cell Therapeutics has a consensus price target of $4.88.

Q

What is the current price for Lineage Cell Therapeutics (LCTX)?

A

The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $0.6531 last updated May 28, 2025 at 7:39 PM EDT.

Q

Does Lineage Cell Therapeutics (LCTX) pay a dividend?

A

There are no upcoming dividends for Lineage Cell Therapeutics.

Q

When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?

A

Lineage Cell Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Q

Is Lineage Cell Therapeutics (LCTX) going to split?

A

There is no upcoming split for Lineage Cell Therapeutics.

Q

What sector and industry does Lineage Cell Therapeutics (LCTX) operate in?

A

Lineage Cell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch